ZURICH/GDANSK, July 14 (Reuters) – Here are some of the main factors that may affect Swiss stocks on Tuesday: NOVARTIS AG Novartis Canada receives Health Canada approval for Vanrafia for proteinuria
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)